➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: June 19, 2021

DrugPatentWatch Database Preview

CEFPROZIL Drug Profile

Email this page to a colleague

« Back to Dashboard

Which patents cover Cefprozil, and when can generic versions of Cefprozil launch?

Cefprozil is a drug marketed by Apotex Inc, Aurobindo Pharma, Lupin, Orchid Hlthcare, Ranbaxy Labs Ltd, Sandoz, Teva Pharms, Aurobindo Pharma Ltd, Chartwell Rx, Teva, and Wockhardt. and is included in fifteen NDAs.

The generic ingredient in CEFPROZIL is cefprozil. There are thirteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the cefprozil profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Cefprozil

A generic version of CEFPROZIL was approved as cefprozil by CHARTWELL RX on November 14th, 2005.

  Get Started Free

US Patents and Regulatory Information for CEFPROZIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva CEFPROZIL cefprozil TABLET;ORAL 065208-002 Dec 6, 2005 AB RX No No   Get Started Free   Get Started Free   Get Started Free
Wockhardt CEFPROZIL cefprozil TABLET;ORAL 065428-001 Jun 14, 2007 DISCN No No   Get Started Free   Get Started Free   Get Started Free
Apotex Inc CEFPROZIL cefprozil FOR SUSPENSION;ORAL 065351-001 Feb 29, 2012 AB RX No No   Get Started Free   Get Started Free   Get Started Free
Aurobindo Pharma Ltd CEFPROZIL cefprozil TABLET;ORAL 065340-002 May 24, 2007 AB RX No No   Get Started Free   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.